Plasma Haloperidol Levels and Clinical Effects in Schizophrenia and Schizoaffective Disorder
Authors:
- Jan VolavkaJVJan Volavka
- Thomas B. CooperTCThomas B. Cooper
- Pal CzoborPCPal Czobor
- Morris MeisnerMMMorris Meisner
- 1 October 1995
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 52 (10) , 837-845
Abstract
From JAMA Psychiatry — Plasma Haloperidol Levels and Clinical Effects in Schizophrenia and Schizoaffective DisorderKeywords
This publication has 26 references indexed in Scilit:
- Neuroleptic discontinuation in the very stable schizophrenic patient: Relapse rates and serum neuroleptic levelsHuman Psychopharmacology: Clinical and Experimental, 1992
- Haloperidol Blood Levels and Clinical EffectsArchives of General Psychiatry, 1992
- Haloperidol plasma levels and clinical response: a therapeutic window relationshipAmerican Journal of Psychiatry, 1992
- Optimal Dose of Neuroleptic in Acute SchizophreniaArchives of General Psychiatry, 1991
- Dosage of Haloperidol for SchizophreniaArchives of General Psychiatry, 1991
- Clinical response and plasma haloperidol levels in chronic and subchronic schizophreniaBiological Psychiatry, 1989
- Dopamine Receptor Occupancy and Plasma Haloperidol LevelsArchives of General Psychiatry, 1989
- Clinical implications of determination of plasma haloperidol levelsActa Psychiatrica Scandinavica, 1989
- Clinical response and plasma haloperidol levels in schizophreniaPsychopharmacology, 1983
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970